Olatoyosi Odenike to Bridged-Ring Compounds
This is a "connection" page, showing publications Olatoyosi Odenike has written about Bridged-Ring Compounds.
Connection Strength
0.926
-
The Next Generation of JAK Inhibitors: an Update on Fedratinib, Momelotonib, and Pacritinib. Curr Hematol Malig Rep. 2020 12; 15(6):409-418.
Score: 0.778
-
Phase 1/2 study of pacritinib, a next generation JAK2/FLT3 inhibitor, in myelofibrosis or other myeloid malignancies. J Hematol Oncol. 2016 12 08; 9(1):137.
Score: 0.148